A Trial-Based Cost-Utility Analysis of a Medication Optimization Intervention Versus Standard Care in Older Adults.
Eirin Guldsten RobinsonHanna GyllenstenJeanette Schultz JohansenKjerstin HavnesAnne Gerd GranasTrine Strand BergmoLars SmåbrekkeBeate Hennie GarciaKjell Hermann HalvorsenPublished in: Drugs & aging (2023)
The IMMENSE trial was registered in ClinicalTrials.gov on 28 June, 2016 before enrolment started (NCT02816086).